Conestoga Capital Advisors, LLC Biolife Solutions Inc Transaction History
Conestoga Capital Advisors, LLC
- $6.22 Billion
- Q3 2025
A detailed history of Conestoga Capital Advisors, LLC transactions in Biolife Solutions Inc stock. As of the latest transaction made, Conestoga Capital Advisors, LLC holds 75,502 shares of BLFS stock, worth $1.82 Million. This represents 0.03% of its overall portfolio holdings.
Number of Shares
75,502
Previous 65,017
16.13%
Holding current value
$1.82 Million
Previous $1.4 Million
37.57%
% of portfolio
0.03%
Previous 0.02%
Shares
20 transactions
Others Institutions Holding BLFS
# of Institutions
206Shares Held
47.6MCall Options Held
12.6KPut Options Held
0-
Casdin Capital, LLC New York, NY6.71MShares$161 Million23.32% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$132 Million0.0% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.07MShares$97.9 Million0.06% of portfolio
-
Invesco Ltd. Atlanta, GA3.6MShares$86.6 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.97MShares$71.4 Million0.0% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.03B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...